American Conference Institute will be holding its 12th annual "Maximizing Pharmaceutical Patent Lifecycles" conference in New York City on October 4-5, 2011. I will have the pleasure of speaking at this conference once again--this time on method-of-use patents and inducement of infringement. The discounted early-registration rate expires Friday, August 12th, so move quickly!
The conference agenda includes:
- Understanding How the Patent Cliff Will Redefine the Endgame
- USPTO Keynote: The Impending Reality of Patent Reform and its Potential Impact on Pharmaceutical Patents
- Life Cycle Management Controversies Posed by the Biosimilars Act
- Patent Term Adjustment and Patent Term Extensions Update: Strategies and Considerations for Small and Large Molecules
- Exploring Post-Issuance PTO Procedures in the Era of the Patent Cliff: Focus on Reexam and Reissue Proceedings
- The Combined Impact of Prior Art Obviousness and Obvious-Type Double Patenting on Pharmaceutical Patent Life Cycle Strategies
- Personalized Medicine and Patent Life Cycle Considerations Vis-a-Vis Sections 101, 112, and Allowable Research Exceptions
- CAFC and Supreme Court Watch: Three Cases That May Have a Radical Impact on Pharmaceutical Patent Life Cycle Strategies
- FTC Keynote: Analysis of Competitive Behaviors in Pharmaceutical Patent Life-Cycle Management Strategies
- REMS Studies and Generic Entry: Exploring the Latest Regulatory Conundrum Affecting Pharmaceutical Patent Life Cycle Strategies
- Carve-Outs, Skinny Labeling and Use Codes: Understanding Their Role in Orange Book Listing Strategies and Life Cycle Management
- Inducement Actions and Divided Infringement: How Method-of-Use Claims Controversies are Influencing Orange Book Listings (I'll be speaking on this panel)
- Exclusivities and Forfeitures: New Developments, Controversies and Concerns
- FDA Keynote: Update on FDA Activities Impacting Pharmaceutical Patent Life Cycles for Small and Large Molecules
- Safe Harbor or Stormy Port? Calming the Legal Tempest Left by Proveris
In addition to the main conference, ACI will offer two pre-conference workshops on October 3rd: "PTA-PTE Boot Camp: Basic Training in the Essentials of Patent Term Adjustment and Patent Term Restoration for Patent Lawyers Serving the Biopharmaceutical Industry"; and "Working Group on Global Pharmaceutical Patent Life Cycle Management Strategies for Established and Emerging Markets: A Practical, Hands-On Guide to Patent Extensions and Exclusivities Available to Pharmaceutical Products Around the World".
Orange Book Blog is a media partner of this conference, so readers are eligible for a $200 discount (beyond any other discounts) by using registration code OBB 200. For more information or to register, please visit the conference website.
Comments